XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 907,828 1,248,115
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 59.59 $ 62.02
Granted (in shares) 0  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (339,649)  
Weighted Average Exercise Price, Exercises in Period (in dollars per share) $ 68.51  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures (638)  
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share) $ 72.15  
Weighted Average Remaining Contractual Term, Outstanding (in years) 5 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding $ 86.2  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 865,198  
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 58.72  
Weighted Average Remaining Contractual Term, Exercisable (in years) 5 years 6 months  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 82.9  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value $ 31.6